SCHEMBL7330263

SCHEMBL7330263

CCOC(=O)CCN1CC(=O)N(Cc2cccc(Oc3ccccc3)c2)c2ccc(I)cc2C1=O

nearest known ligand 0.44

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CCR8 P51685 3/20 0.44
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
LMNA P02545 2/20 0.35
GAA P10253 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7323943 0.93 CHRM5 (0.40) CCR8KMT2AMEN1ALDH1A1LMNA
SCHEMBL7335737 0.87 CTRB1 (0.41) KMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL7328570 0.85 POLB (0.45) ALDH1A1LMNA
SCHEMBL7328979 0.84 HDAC6 (0.41) KMT2AMEN1KDM4EALDH1A1LMNA
SCHEMBL7319614 0.82 TNF (0.38) KMT2AKDM4EALDH1A1LMNA
SCHEMBL7329514 0.81 HSP90AA1 (0.43) KDM4EALDH1A1
SCHEMBL7323040 0.80 SIGMAR1 (0.37) CCR8KMT2AMEN1
SCHEMBL7322297 0.80 SIGMAR1 (0.37) CCR8KMT2AMEN1
SCHEMBL7332495 0.79 ALDH1A1 (0.40) KMT2AMEN1KDM4EALDH1A1LMNA
SCHEMBL7325381 0.78 ITGB3 (0.46) KMT2AMEN1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5674863-A BENZODIAZEPINEDIONE DERIVATIVE; FIBRINOGIN BINDING INHIBITOR GENENTECH, INC. (US) 1997-10-07 US disclosed
US-5674865-A BENZODIAZEPINEDIONE DERIVATIVE; FIBRINOGIN BINDING INHIBITOR GENENTECH, INC. (US) 1997-10-07 US disclosed
US-5663166-A ANTICOAGULANTS OF 1,4-BENZODIAZEPINE-2,5-DIONE AND 2-BENZOAZEPINE-1,4-DIONE DERIVATIVES; PREVENTS FIBRINOGEN BINDING NECESSARY FOR PLATELET AGGREGATION; SIDE EFFECT REDUCTION, E.G. EXCESSIVE BLEEDING GENENTECH, INC. (US) 1997-09-02 US disclosed
US-5565449-A PLATELET AGGREGATION INHIBITORS GENENTECH, INC. (US) 1996-10-15 US disclosed
EP-0610334-B1 NONPEPTIDYL INTEGRIN INHIBITORS HAVING SPECIFICITY FOR THE GPII B III A RECEPTOR GENENTECH INC (US) 1996-01-24 EP disclosed
US-5403836-A Anticoagulants GENENTECH, INC. (US) 1995-04-04 US disclosed
US-5250679-A Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor GENENTECH, INC. (US) 1993-10-05 US disclosed
WO-1993008174-A1 NONPEPTIDYL INTEGRIN INHIBITORS HAVING SPECIFICITY FOR THE GPIIbIIIa RECEPTOR GENENTECH, INC. (US) 1993-04-29 WO disclosed